Holland Capital Invests in Curess
Amsterdam, June 20th, 2024 – Holland Capital participates in Curess, a leading organization in youth care focused on systemic family support. Through the collaboration with Holland Capital, further growth and development can be achieved.
Systemic Family Support
Curess offers specialized ambulatory youth care (such as intensive systemic guidance, ambulatory emergency help, perspective research, and co-parenting investigations) and focuses on strengthening families through practical and directly applicable assistance. Curess operates without waiting lists and can scale its operations up and down quickly, to deliver the desired care swiftly and with high quality. The organization achieves this by applying self-developed software that supports core processes (such as planning) and thus reduces administrative pressure.
Strategic Parntership
With this strategic partnership, Curess has found a partner to achieve its ambitious strategic goals.
Eddy de Bruin, CEO of Curess, states: “With the support of Holland Capital, we can realize our ambitions and help even more young people and families. With their expertise and resources, we are better equipped to significantly increase our impact in youth care. We are committed to providing the necessary support to families to learn to live together better, without waiting lists, through our dedicated professionals.”
Margot Engels, Healthcare Partner at Holland Capital, adds: “We are proud to add Curess to our portfolio. Curess provides crucial support to families in an innovative way, and we look forward to working together on their growth ambitions and further professionalization of their services. Our shared vision is to provide the best possible care and support.”
About Curess
With over 200 registered professionals, Curess offers specialized ambulatory youth care to young people and families to ensure they can live together better. By utilizing personal and innovative methods, Curess strives for a safe and supportive environment for children and their families. Curess is active in the regions of Twente, Midden-IJssel, Oost-Veluwe, Noord-Veluwe, Achterhoek, and Zuid-Drenthe
About Holland Capital
Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The team understands entrepreneurship and strives for an open, sustainable, and professional relationship with the management teams of the companies they invest in, with the common goal of realizing growth. Holland Capital has offices in Amsterdam and Düsseldorf. With specialized sector teams, it focuses on the Healthcare, Technology, and Agrifood-Tech sectors. They understand the dynamics and opportunities, and have an extensive network in these sectors.
The participation in Curess fits within Holland Capital’s strategy to invest in companies that contribute to societal challenges and create value for society. With this investment, Holland Capital takes an important step in further strengthening its portfolio within the healthcare sector.
Holland Capital supports the growth of Chainresult and Supply Chain Company
Amsterdam, 10 July 2023 - Investment company Holland Capital is investing in Chainresult and Supply Chain Company, two renowned players in the digitalization of the food & agri value chain. The investment by Holland Capital enables the organizations to realize...
Holland Capital invests in terminal home care organization Attenza
Amsterdam, 15 June 2023 – Holland Capital invests in Attenza, a care organization specialized in offering terminal palliative care at home. With the investment Attenza can execute its ambitious growth path. Palliative terminal care The aging population in the...
Holland Capital invests in House of Clouds and Synobsys
Amsterdam, May 9th, 2023 - Holland Capital invests in House of Clouds and Synobsys, two renowned players in the field of Intelligent Automation. Holland Capital's investment ensures that their growth ambitions can be realised. Intelligent Automation Intelligent...
Holland Capital sells its stake in Valori
Amsterdam/Utrecht, 4 April 2023 – Holland Capital sells its stake in Valori to Cerios. Valori believes that embedding integral quality into IT systems is crucial to allow carefree innovation. The Quality Assurance and Test Consultants of Valori build towards the...
Sirius Medical announces major funding round to further accelerate sales growth and new product development
Sirius Pintuition® – Moving from Localization to Surgical Marker Navigation Eindhoven, Netherlands – 28 March 2023 – Our portfolio company Sirius Medical, the leader in surgical marker navigation, today announced the successful closing of a Series B Round 12 M€. The...
YOEP joins forces with De Praktische GGZ
Amsterdam, 14 March 2023 – Our portfolio company YOEP will collaborate with De Praktische GGZ. The combination, made possible by Holland Capital, will further create an organisation with a wide range of both youth assistance and mental healthcare. De Praktische GGZ...

Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl